National Institute for Health and Care Excellence. (2017) Liver disease. London: NICE. Quality standard QS152.
Preview | Title | Contact |
---|---|---|
|
PDF (Liver disease)
139kB |
External website: https://www.nice.org.uk/guidance/QS152
This quality standard covers identifying, assessing and managing chronic liver disease in children, young people and adults, and cirrhosis in young people and adults. It describes high-quality care in priority areas for improvement.
Statement 1 People with non‑alcoholic fatty liver disease are given advice on physical activity, diet and alcohol.
Statement 2 People with non‑alcoholic fatty liver disease are offered regular testing for advanced liver fibrosis.
Statement 3 Young people and adults with risk factors for cirrhosis are offered non‑invasive testing for cirrhosis.
Statement 4 Adults with cirrhosis are offered 6‑monthly surveillance for hepatocellular carcinoma.
Statement 5 Young people and adults with cirrhosis and upper gastrointestinal bleeding are given prophylactic intravenous antibiotics at presentation.
G Health and disease > State of health > Physical health
G Health and disease > Digestive system disease > Liver disease
G Health and disease > Digestive system disease > Liver disease > Liver cirrhosis
J Health care, prevention, harm reduction and treatment > Patient / client care management
J Health care, prevention, harm reduction and treatment > Health care delivery
MP-MR Policy, planning, economics, work and social services > Programme planning, implementation, and evaluation > Quality standards
T Demographic characteristics > Substance or health care worker / provider
T Demographic characteristics > Doctor / physician
VA Geographic area > Europe > United Kingdom
Repository Staff Only: item control page